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ProliferationWe demonstrate that HPV-16 E7 forms a complex with Miz-1. UV-induced expression of the CDK-inhibitor
p21Cip1 and subsequent cell cycle arrest depends upon endogenous Miz-1 in HPV-negative C33A cervical can-
cer cells containing mutated p53. Transient expression of E7 in C33A inhibits UV-induced expression of
p21Cip1 and overcomes Miz-1-induced G1-phase arrest. The C-terminal E7Δ79LEDLL83-mutant with reduced
Miz-1-binding capacity was impaired in its capability to repress p21Cip1 expression; whereas the pRB-
binding-deﬁcient E7C24G-mutant inhibited p21Cip1 expression similar to wild-type E7. Using ChIP, we dem-
onstrate that endogenous E7 is bound to the endogenous p21Cip1 core-promoter in CaSki cells and RNAi-
mediated knock down of Miz-1 abrogates E7-binding to the p21Cip1 promoter. Co-expression of E7 with
Miz-1 inhibited Miz-1-induced p21Cip1 expression from the minimal-promoter via Miz-1 DNA-binding
sites. Co-expression of E7Δ79LEDLL83 did not inhibit Miz-1-induced p21Cip1 expression. E7C24G retained
E7-wild-type capability to inhibit Miz-1-dependent transactivation. These ﬁndings suggest that HPV-16 E7
can repress Miz-1-induced p21Cip1 gene expression.
© 2011 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
High-risk human papillomaviruses (HPVs) are the major etiological
agents for cervical cancer (zur Hausen, 2002). HPV-16 is the most preva-
lent high-risk genotype (Munoz et al., 2003). Co-expression of the early
viral genes E6 and E7 is necessary and sufﬁcient to immortalize primary
human keratinocytes (Münger et al., 1989) and to maintain the trans-
formed phenotype of cervical cancer cells (DeFilippis et al., 2003;
Francis et al., 2000; Goodwin and DiMaio, 2000). E7 is the major HPV
oncoprotein and its expression is sufﬁcient to immortalize primary
human epithelial cells at a low frequency (Halbert et al., 1991;
Reznikoff et al., 1994; Wazer et al., 1995) and to induce cervical cancer
in transgenic mice treated with estrogens (Riley et al., 2003). This is con-
sistent with the strong increase of the HPV-16 E7 protein levels during
cervical carcinogenesis and with high level expression of HPV-16 E7 in
cervical cancers (Fiedler et al., 2004). According to the current model,rentiation Research Group, In-
y of Sciences and Tumor Virol-
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werschke).
Y-NC-ND license.E7 acts mechanistically through interaction with cellular regulatory pro-
tein complexes and alter, or neutralize, their normal functions
(McLaughlin-Drubin and Munger, 2009; Pim and Banks, 2010). This
leads to impaired cell cycle arrest responses and deregulation of path-
ways controlling cellular differentiation and apoptosis. Moreover, E7
elicits genomic instability and reprograms cellular metabolic pathways.
The transforming activity of E7 was linked to its interaction with the ret-
inoblastoma protein (pRB) and abrogation of the growth-suppressive
function of pRB (Dyson et al., 1989), resulting in transcriptional activation
of genes necessary for S-phase entry and progression (McLaughlin-
Drubin andMunger, 2009). E7mutants that are unable to bind pRB retain
however transforming capacity (Funk et al., 1997), and E7 mutants with
reduced transforming activity retain the ability to bind pRB (Massimi et
al., 1997; Phelps et al., 1992). Moreover, E7 stimulates proliferation inde-
pendently of its ability to associate with pRB (Caldeira et al., 2000). In
keeping with these ﬁndings, critical roles for non-pRB targets of HPV-16
E7 have been demonstrated (Balsitis et al., 2006), including proteins in-
volved in transcriptional activation and chromatin-remodelling (Bernat
et al., 2003; Brehm et al., 1999; Prathapam et al., 2001).While these ﬁnd-
ings suggest that HPV-16 E7 has functions in transcriptional activation,
little is known about a potential role of E7 in transcriptional repression.
Activation of the tumor suppressor p53 by DNA-damage induces cell
cycle arrest mediated, at least in part, by transcriptional activation of the
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Growth arrest by induction of p53 in DNA-damaged keratinocytes is
bypassed by HPV-16 E7 (Demers et al., 1994; Slebos et al., 1994) although
E7was found to stabilize p53 (Seavey et al., 1999). In keepingwith studies
showing that p21Cip1 gene expression is modulated by other signals inde-
pendently of p53 (Macleod et al., 1995), these data suggest that E7 mod-
iﬁes pathways downstream or independently of p53 to allow cell
division. However, the underlying mechanisms are not well understood.
Immortalization of keratinocytes co-expressing HPV-16 E7 and oncogenic
c-Myc is independent of p53 (Liu et al., 2007). C-Myc is amajor transform-
ing protein in human cancer with several functions such as inducing cell
cycle progression (Bornkamm, 2009). C-Myc is a transcriptional regulator
with the ability to activate some target genes while repressing others
(Wanzel et al., 2003). The mechanisms by which c-Myc negatively regu-
lates transcription are less well understood. According to the current
model c-Myc represses transcriptionwhen tethered to promoters by tran-
scriptional activators (Wanzel et al., 2003), as shown forMiz-1 (Myc-inter-
acting zinc-ﬁnger protein-1), a transcription factor involved in
transcriptional activation of the p15Ink4b gene after TGF-β stimulation
(Seoane et al., 2001; Staller et al., 2001) and the p21Cip1 gene in response
to UV-irradiation induced DNA damage (Herold et al., 2002; Seoane et
al., 2002). Miz-1 can bind directly to speciﬁc DNA sequences in the core
promoter close to the start sites of the p21Cip1 gene and activate transcrip-
tion (Herold et al., 2002;Wuet al., 2003).Miz-1-dependent transactivation
can be repressed by aMiz-1-bound c-Myc through disruption of the inter-
action between Miz-1 and co-activators (Herold et al., 2002; Staller et al.,
2001). The repression of p21Cip1 expression by c-Myc leads to enhanced
cyclin E and cyclin A dependent kinase activity and hence cell-cycle pro-
gression of c-Myc-transformed cells despite DNA damage (Herold et al.,
2002; Seoane et al., 2002).
In this study, we searched for novel cellular E7-binding proteins
involved in cell cycle control. We found that HPV-16 E7 forms a com-
plex with the anti-proliferative protein Miz-1. The transcription of
p21Cip1 is regulated by Miz-1 as well as by p53 (Seoane et al.,
2002). Moreover, cell cycle arrest induced by p53 in response to
DNA damage can be bypassed by HPV-16 E7 (Demers et al., 1994;
Slebos et al., 1994). For these reasons, we studied the effects of the
E7/Miz-1 interaction on the regulation of p21Cip1 gene expression
and cell cycle progression in response to UV-induced DNA damage
in the HPV-negative C33A cervical cancer cells which harbor an inac-
tive p53 protein mutated in the DNA binding domain (Crook et al.,
1991; Scheffner et al., 1991).
Results
Interaction between HPV-16 E7 and Miz-1
We searched for novel cellular HPV-16 E7-binding proteins in-
volved in cell cycle control in a yeast two-hybrid screen using the in-
tact carboxyl-terminal domain of HPV-16 E7 as bait. In this screen we
isolated cDNAs coding for carboxyl-terminal fragments of Myc-
interacting zinc-ﬁnger protein-1 (Miz-1) alias zinc ﬁnger and BTB do-
main containing 17(ZBTB17) (Staller et al., 2001). A speciﬁc and
strong interaction of Miz-1(aa331–803), encoding for the zinc-ﬁnger
domains 2–13, with HPV-16 E7 but not with unrelated proteins was
demonstrated in yeast using two distinct reporter genes, leu2::
lexAo6-pLEU2 (Fig. 1A, left panels) and LexAo8-Gal1-lacZ::URA3
(Fig. 1A, right panels).
To determine whether both full length proteins can interact, puri-
ﬁed GST-HPV-16 E7 was incubated with extracts from Miz-1 wild-
type expressing cells. Miz-1 speciﬁcally bound to GST-HPV-16 E7 in
this assay, whereas no binding was observed for GST alone (Fig. 1B,
left panel), suggesting that both proteins interact in vitro. The E7 pro-
tein of the non-transforming low-risk HPV-11 bound with lower efﬁ-
ciency as HPV-16 E7 to Miz-1 in the GST pull down assays (Fig. 1B, left
panel). To further map the binding site for Miz-1 in HPV-16 E7 a set ofpoint and deletion mutants of E7 (Fig. 1C) was investigated for Miz-1-
binding in the GST pull down assay. The conserved domain 2 (cd2) as
well as the carboxyl-terminal domain (cd3) is essential for the trans-
forming potential of HPV-16 E7 (Massimi et al., 1997; Phelps et al.,
1992; Prathapam et al., 2001; Santer et al., 2007). These domains
have been deﬁned by inactivating mutations in cd2 (C24G) (Phelps
et al., 1992) and cd3 (Δ79LEDLL83 (Massimi et al., 1997),
Δ52YNIVT56 (Prathapam et al., 2001). Cd2 mutants are deﬁcient in
binding to pRB and some additional cellular proteins (McLaughlin-
Drubin and Munger, 2009). The cd3 mutants are, for example, deﬁ-
cient in binding to IGF binding protein-3 (Santer et al., 2007) or the
metabolic regulator pyruvate kinase M2 (Zwerschke et al., 1999).
E7C24G bound Miz-1 with wild-type efﬁciency (Fig. 1B, right
panel), suggesting that the interaction with Miz-1 is not a function
of cd2. In contrast, the two C-terminal mutants Δ79LEDLL83 and
Δ52YNIVT56 showed signiﬁcantly reduced binding to Miz-1
(Fig. 1B, right panel). These data are in accordance with the fact that
a C-terminal E7 fragment was used as the bait in the yeast two-
hybrid screen. Moreover, these ﬁndings underline that E7 speciﬁcally
interacts with Miz-1 and suggest that a region encompassing amino
acids 52–83 within the α1-helix of the conserved E7 C-terminal zinc-
binding fold (Ohlenschlager et al., 2006), but not the conserved domain
2, is necessary for the interaction with Miz-1.
To analyze whether E7/Miz-1 complexes exist in human cells, co-
immunoprecipitation experiments were performed from lysates of U-
2OS osteosarcoma cells transiently overexpressing HPV-16 E7 and
Miz-1 (Fig. 2A). E7 was speciﬁcally co-precipitated with Miz-1 using
anti-Miz-1 antibodies, but not with an unrelated isotypic control an-
tibody (Fig. 2A). Antibodies against HPV-16 E7 precipitated E7 from
U-2OS extracts and co-precipitation of Miz-1 was observed
(Fig. 2A). Unrelated polyclonal control serum precipitated neither
HPV-16 E7 nor Miz-1, underlining the speciﬁcity of the immunopre-
cipitations (Fig. 2A). The mouse monoclonal anti-Miz-1 antibody
10E2 recognizes more than one band of endogenous Miz-1 in
human cancer cell extracts in western blotting experiments
(Herkert et al., 2010; Herold et al., 2008; Wanzel et al., 2005). These
bands represent most likely post-translational modiﬁed forms of
Miz-1, such as differentially phosphorylated Miz-1 (Wanzel et al.,
2005) and sumoylated Miz-1 (Herkert et al., 2010). We conducted a
western blot experiment to analyze which forms of endogenous
Miz-1 exist in cervical cancer cells (Fig. 2B). In CaSki cells the anti-
Miz-1 antibodies recognized three major bands. Long exposure
revealed however that additional forms of Miz-1 exist in low quanti-
ties (Fig. 2B). Similar results were found in HeLa and C33A cells al-
though the abundance of the corresponding bands was somewhat
different between the given cervical cancer cell lines (Fig. 2B). Com-
parison of endogenous Miz-1 and ectopically overexpressed Miz-1,
especially in the long exposure, demonstrated the speciﬁcity of the
endogenous Miz-1 bands (Fig. 2B). To determine whether the endog-
enous HPV-16 E7 and Miz-1 proteins can form a complex, CaSki cell
lysates were immunoprecipitated with the anti HPV-16 E7
RabMab42-3 (Dreier et al., 2011), rabbit pre-immune serum served
as a negative control (Fig. 2C). Immunoblotting showed that Miz-1
was speciﬁcally detected in anti-HPV-16 E7 immunoprecipitates, nei-
ther protein was present in the control immunoprecipitate (Fig. 2C).
Interestingly, the anti-HPV-16 E7 RabMab42-3 immunoprecipitated
only two Miz-1 bands (Fig. 2C). These ﬁndings suggest that HPV-16
E7 can form a complex with two forms of Miz-1 in living cervical can-
cer cells.
HPV-16 E7 represses Miz-1-induced expression of the endogenous
p21Cip1 gene after UV irradiation in C33A cervical cancer cells
Like p53 (Dulic et al., 1994), Miz-1 can induce p21Cip1 gene ex-
pression and subsequent cell cycle arrest in response to UV irradia-
tion in immortalized human keratinocytes (Herold et al., 2002).
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moter in a p53-independent manner (Herold et al., 2002; Seoane et
al., 2002). We investigated whether E7 interferes with Miz-1-
dependent transcriptional control of the p21Cip1 gene after DNA dam-
age. To rule out any confounding effects by p53 the E7/Miz-1 interac-
tion was studied in C33A cervical cancer cells which harbor an
inactive p53 protein mutated in the DNA-binding domain (Crook et
al., 1991; Scheffner et al., 1991). To analyze whether Miz-1 is essential
for the induction of the p21Cip1 gene in response to UV irradiation in
C33A cells, we used small interfering RNA duplexes (siRNAs) to knock
down the expression of endogenous Miz-1. Depletion of the Miz-1
protein (Figs. 3A and C) resulted in a substantial abrogation of UV-
induced expression of the endogenous p21Cip1 gene, relative to
C33A cells transiently transfected with control siRNA, as shown in re-
duced p21Cip1 mRNA levels (Fig. 3B) as well as reduced p21Cip1 pro-
tein levels (Fig. 3C). These ﬁndings indicate that Miz-1 mediates
UV-dependent induction of the p21Cip1 gene in the p53 negative
C33A cells. To investigate the effect of HPV-16 E7 on UV-induced
p21Cip1 gene expression in this system, C33A cells were transiently
transfected with pX-HPV-16 E7 (Fig. 3C) and the endogenous
p21Cip1 mRNA levels were measured after UV irradiation by quantita-
tive RT-PCR analysis (Fig. 3B). Similar to the depletion of Miz-1, the
expression of HPV-16 E7 resulted in a dramatic abrogation of UV-
dependent induction of p21Cip1 gene expression. The transient ex-
pression of HPV-16 E7 resulted also in reduced p21Cip1 protein level
in the UV-irradiated C33A cells (Fig. 3C). This suggests that HPV-16
E7 can abrogate UV-induced expression of endogenous p21Cip1 in a
p53-independent manner.
From the Miz-1 western blot shown in Fig. 3C it seemed possible
that the Miz-1 levels are somewhat reduced when E7 is expressed.
Since this could be important for the underlying mechanism, we con-
ducted western blot experiments to prove whether HPV-16 E7 has
impact on the endogenous Miz-1 protein levels (Fig. 3D). We found
that the Miz-1 protein levels did not change in E7 expressing cells.
The Miz-1 protein levels were increased in CaSki cells and in the sta-
ble cell lines NHEK/HPV-16 E6 and NHEK/HPV-16 E7 relative to nor-
mal human epidermal keratinocytes (NHEK), suggesting that the
Miz-1 levels are increased in immortalized and transformed cells.
The Miz-1 protein levels were however similar in NHEK/HPV-16 E7
and in the NHEK/HPV-16 E6 control cells (Fig. 3D, left panel). More-
over, transient overexpression of HPV-16 E7 in experimental cell
lines led not to strong changes in the Miz-1 levels (Fig. 3D, right
panel and data not shown). The analysis of the impact of HPV-16 E7
on the Miz-1 levels warrants further studies.
Our ﬁndings that HPV-16 E7 blocks Miz-1-dependent transactiva-
tion of the p21Cip1 gene in UV-irradiated C33A cells raise the possibil-
ity that the ability of E7 to activate cell proliferation involves its
ability to block Miz-1-induced p21Cip1 gene expression. To determine
whether E7 can override UV-induced, Miz-1-dependent G1-cell cycleFig. 1. Analysis of the HPV-16 E7/Miz-1 interaction. (A) Yeast strain EGY48/pSH1834 (M
operator-LEU2 and a LexA operator-lacZ gene (Zwerschke et al., 1999) was used for both the
various LexA fusion proteins (Zwerschke et al., 1999) from pEG202::HIS3 vectors as indi
expressing the unfused B42 transactivation domain (Zwerschke et al., 1999), was used as n
totrophy and grown in glucose minimal medium (Ura-, His-, Trp-). (Left panel) Yeast cells
the following nutrient conditions: Control: Glucose minimal medium with leucine; all stra
protein independent activation of the LexAo6-LEU2 reporter. Galactose: galactose minim
the LexAo6-pLEU2 gene. (Right panel) The yeast cells, containing the LexA operator-lacZ gen
teins and the B42-Miz-1331-803 prey or B42 as indicated, were streaked out onto Galactose
dependent activation of the lexAo8-Gal1-lacZ::URA3 gene expressing the β-galactosidase en
in GST pull down experiments. (Left panel) Puriﬁed GST, GST-HPV-11 E7 and GST-HPV-16 E
whole-cell extracts from C33A cells overexpressing the full length Miz-1 protein, as indicate
Miz-1 protein that was retained was determined by direct immunoblotting using a monoc
trolled by Coomassie staining. (Right panel) (Top) GST pull downs with various GST-HPV-16
bands were scanned from low exposures and densitometrically analyzed for quantiﬁcation (
blots shown are from one membrane which was cut after ﬁnishing the western blot proce
(CXXC) are indicated. The mutants of E7 used in the assays are shown.arrest in C33A cells, a transient transfection assay was established
which allows monitoring of the ability of E7 to override G1-arrest.
To this end, normal proliferating C33A cells were transiently trans-
fected with expression vectors for E7, Miz-1 or empty vector. 24 h
after UV irradiation, cell cycle distribution was analyzed among the
surviving cell population using FACS analysis (Fig. 3E). In the C33A
cells transiently overexpressing Miz-1, the number of G1-phase cells
was considerably increased (Fig. 3E), whereas transient co-
expression of E7 with Miz-1 abrogated Miz-1-induced G1-cell cycle
arrest. This indicates that E7 can override Miz-1-mediated G1-cell
cycle arrest induced after DNA damage.
To further address the question whether E7-induced downregula-
tion of p21Cip1 is Miz-1-dependent, we studied whether the two
carboxyl-terminal HPV-16 E7 mutants, which have reduced Miz-1-
binding capacity, are impaired in their ability to repress UV-induced ex-
pression of the endogenous p21Cip1 gene. C33A cells were transiently
transfected either with pX-HPV-16 E7 wild-type, pX-HPV-16
E7Δ79LEDLL83, pX-HPV-16 E7Δ52YNIVT56, pX-HPV-16 E7C24G or
pX, as indicated (Fig. 4A), and UV-irradiation induced p21Cip1 gene ex-
pression was studied by quantitative RT-PCR analysis (Fig. 4B). We
found that the low efﬁciency Miz-1-binding HPV-16 E7Δ79LEDLL83
mutant signiﬁcantly lost the ability to repress UV-irradiation induced
expression of the endogenous p21Cip1 gene. This underlines the speci-
ﬁcity of the repressive effect of HPV-16 E7 onMiz-1-dependent transac-
tivation of the p21Cip1 gene and indicates that the 79LEDLL83 motif
within the α1-helix in the C-terminal zinc-ﬁnger loop of HPV-16 E7 is
necessary for repression of the p21Cip1 gene. The secondC-terminalmu-
tant, E7Δ52YNIVT56, showed a tendency to reduced repressing activity
but expression was slightly lower than for wild-type E7. The cd2-
mutant E7C24G repressed the p21Cip1 gene expression to a similar ex-
tent as wild-type E7 (Fig. 4B), suggesting that E7-induced repression
of Miz-1-induced p21Cip1 gene expression is pRB-independent. These
data further support the model that HPV-16 E7-induced downregula-
tion of p21Cip1 is Miz-1-dependent. The data underline also that the
HPV-16 E7/Miz-1 interaction contributes to the transforming potential
of the virus, because the HPV-16 E7Δ79LEDLL83 mutation has reduced
transforming activity (Massimi et al., 1997). To further address the
questionwhether the E7/Miz1 interaction is important for cell transfor-
mation we analyzed whether the low-risk HPV-11 E7 protein has the
ability to repress UV-induced expression of the endogenous p21Cip1
gene. HPV-11 E7 was transiently expressed in C33A cells (Fig. 4C), and
UV-irradiation induced p21Cip1 gene expression measured by quantita-
tive PCR analysis (Fig. 4B). We found that HPV-11 E7 could not repress
UV-irradiation induced expression of the endogenous p21Cip1 gene. This
underlines that the HPV-16 E7/Miz-1 interaction contributes to the
transforming potential of the virus. Moreover, these data indicate that
HPV-11 E7, although it binds to Miz-1 in the GST pull downs (Fig. 1),
does not have the biochemical activity of HPV-16 E7 to repress UV-
induced p21Cip1 transcription. Moreover, it was shown that low-riskatα, his3, ura3, trp1, leu2::lexAo6-pLEU2/lexAo8-Gal1-lacZ::URA3) containing a LexA
LEU2 and β-galactosidase reporter gene assays. EGY48/pSH1834 derivatives expressing
cated were transformed with the plasmid pB42-Miz-1-331-803::TRP1. pJG4-5::TRP1,
egative control. Transformants were selected for uracil, histidine and tryptophan pro-
were dropped out onto each of three plates and incubated for 4 days at 30 °C under
ins grow. Glucose: glucose minimal medium without leucine; selection for B42 fusion
al medium without leucine; selecting for B42 fusion protein-dependent activation of
e (LexAo8-GAL1-LacZ::URA3) on pSH1834 and expressing the various LexA fusion pro-
+Leu+X-Gal plates and incubated for 4 days at 30 °C: Selecting for B42 fusion protein-
zyme, as indicated by the generation of the blue colour. (B) HPV E7 interacts with Miz-1
7 fusion proteins immobilized on glutathione sepharose 4B beads were incubated with
d. (Top) After washing, bound proteins were separated by SDS-PAGE and the amount of
lonal anti-Miz-1 antibody. (Bottom) Input of the various GST fusion proteins was con-
E7 mutants are shown as indicated. (Bottom) The Miz-1 western blot and GST protein
n=3). The Miz-1 protein bound to HPV-16 E7 wild-type was set to 100%. The western
dure. (C) Structure of the HPV-16 E7 protein. Cd1, cd2, cd3 and the zinc-ﬁnger motifs
245D. Morandell et al. / Virology 422 (2012) 242–253HPV-11 E7 does not bypass DNA damage induced G1 arrest (DeWeese
et al., 1997). Together these data indicate thatHPV-11 E7 can neither re-
press UV-induced p21Cip1 gene expression nor override UV-induced
G1-cell cycle arrest. This suggests that the binding of HPV-11 E7 to
Miz-1, as shown in our GST pull down experiments (Fig. 1), is not sufﬁ-
cient for the inactivation of Miz-1 induced G1 cell cycle arrest and UV-
induced p21Cip1 transcription.HPV-16 E7 binds to the p21Cip1 core promoter and represses Miz-1-
induced expression from the Miz-1 binding sites
Having demonstrated that E7 forms a complex with Miz-1 and re-
presses UV-induced p21Cip1 gene expression in a Miz-1-dependent
manner, we aimed to further address the underlying mechanism. It
is known that Miz-1 is bound to the consensus initiator sequence
246 D. Morandell et al. / Virology 422 (2012) 242–253(−40/+20) at the start site of transcription on the p21Cip1 promoter
(Fig. 5A) and induces p21Cip1 gene expression in UV-irradiated cells
(Herold et al., 2002). We tested in chromatin-immunoprecipitation
(ChIP) experiments whether endogenous HPV-16 E7 is bound to the
endogenous p21Cip1 core promoter in CaSki cervical cancer cells,ﬁrst without UV irradiation (Fig. 5B, left panels). ChIP was performed
using the rabbit monoclonal anti-HPV-16 E7 antibody (RabMab-42-3,
Dreier et al., 2011), and the precipitates were monitored by RT-PCR
for the content of the human p21Cip1 promoter DNA region from
−46 to +156. Under these conditions the anti-HPV-16 E7 antibody
speciﬁcally co-precipitated p21Cip1 promoter (−46/+156) DNA, as
corroborated by sequencing. The anti-Miz-1 antibody and the anti-
histone H3 antibody (positive control) also co-precipitated p21Cip1
promoter (−46/+156) DNA, while the negative control, rabbit pre-
immune serum, did not (Fig. 5B, left panels). Next, we tested whether
endogenous HPV-16 E7 and Miz-1 are also bound to the endogenous
p21Cip1 promoter in UV-irradiated CaSki cells (Fig. 5B, right panels).
Also under these conditions both the anti-HPV-16 E7 antibody and
the anti-Miz-1 antibody speciﬁcally co-precipitated p21Cip1 promoter
(−46/+156) DNA. Our protein-protein interaction studies suggest
that HPV-16 E7 can form a complex with Miz-1 in CaSki cells (see
below, Fig. 2). To further analyze whether Miz-1 is an anchor for
HPV-16 E7 on the p21Cip1 core promoter, Miz-1 was knocked down
in CaSki cells by RNAi (Fig. 5C) and ChIPs were conducted using the
anti-HPV-16 E7 and anti-Miz-1 antibodies, respectively (Fig. 5D). As
expected in this experiment the anti-Miz-1 antibodies did not co-
precipitate p21Cip1 promoter DNA. The anti-HPV-16 E7 antibody did
also not co-precipitate p21Cip1 promoter (−46/+156) DNA in the
Miz-1 knock down cells, suggesting that the binding of HPV-16 E7
to the p21Cip1 promoter is dependent on Miz-1. Together, our data in-
dicate that a HPV-16 E7/Miz-1 complex is bound to the p21Cip1 core
promoter irrespective of UV irradiation. Moreover, the data suggest
that HPV-16 E7 does not prevent Miz-1-binding to the promoter but
rather blocks the ability of Miz-1 to transactivate.
To further investigate whether E7 represses p21Cip1 gene expres-
sion by interaction with Miz-1 on the p21Cip1-core promoter, we an-
alyzed whether E7 can inhibit Miz-1-dependent transactivation of the
p21Cip1 core promoter (−93/+20) on pGL3p21min, which contains
the Miz-1 consensus elements (Fig. 6A). The experiments were con-
ducted in U-2OS cells which display intrinsic high transfection efﬁ-
ciency. U-2OS cells were transiently transfected with the
pGL3p21min reporter plasmid, pUHDMiz-1 and increasing amounts
of pxHPV16 E7 (Fig. 6B). Overexpressed Miz-1 activated transcription
of the p21Cip1 minimal promoter (Fig. 6B). Co-expression of E7 caused
a considerable abrogation of Miz-1-dependent transactivation of the
p21Cip1 minimal promoter in a dose-dependent manner (Fig. 6B),
suggesting that E7 can repress the transcriptional activity of Miz-1
on the p21Cip1 core promoter. To determine which domain in E7 is
relevant for the repression of Miz-1-dependent induction of the
p21Cip1 core promoter, E7 mutants were investigated in co-
transfection experiments. All E7 proteins were well expressed in the
U-2OS cells (Fig. 6C). While co-transfection of Miz-1 and the cd2-
mutant E7C24G repressed transactivation by Miz-1 with activity sim-
ilar to that of wild-type E7, the repressing activity of the twoFig. 2. InteractionofMiz-1andHPV-16E7incervicalcancercells.(A)HPV-16E7formsacomplexwith
Miz-1 in U-2OS cells. U-2OS cells were co-transfectedwith pUHDMiz-1 and pXHPV-16 E7. 24 h later,
cell lysateswere prepared and subjected to immunoprecipitation using antibodies against HPV-16 E7,
Miz-1 and isotypic control antibodies, as indicated. Cell lysate was used as input control. Precipitated
proteins (Miz-1 and 16 E7) were separated on a 12.5% SDS-PAGE and detected by western blotting.
(B)DetectionofMiz-1 protein in cervical cancer cell lines. Cell lysateswereprepared fromC33A, CaSki,
HeLa, U-2OS and U-2OS cells transiently transfected with pUHDMiz-1 (positive control). Cell lysates
were separated on a 10% SDS-PAGE and Miz-1 protein was detected by western blotting using anti-
Miz-1 10E2 antibodies. Three different exposures, long,mid and short, are shown. The Miz-1 bands
are indicated by arrows. M2-PK served as input control for this experiment. (C) Interac-
tion of endogenous HPV-16 E7 and Miz-1 in CaSki cells. CaSki cell lysates were prepared
and subjected to immunoprecipitation using the anti-HPV-16 E7 RabMab42-3 and poly-
clonal rabbit control serum, as indicated. Cell lysatewas used as input control. Precipitat-
ed proteins (Miz-1 and 16 E7) were separated on a SDS-PAGE and detected by western
blotting using afﬁnity-puriﬁed polyclonal rabbit anti-HPV-16 E7 antibodies and the
mouse monoclonal anti-Miz-1 antibody 10E2. The Miz-1 bands are indicated by arrows.
Fig. 3. Impact of siRNA-mediated knock down of endogenous Miz-1 and ectopic expression of HPV-16 E7, respectively, on UV-induced expression of p21Cip1in C33A cells. (A)
The siRNA oligonucleotide-mediated knock down of Miz-1 in C33A cells is shown (upper panel); siRNA oligonucleotide mixes were used for both Miz-1 and control siRNA (see
ref. Herold et al., 2008). The Miz-1 bands are indicated by arrows. In the siRNA knock down the upper Miz-1 band is fully diminished and the faster migrating, more abundant,
Miz-1 band is also reduced. Actin served as input control (lower panel). (B) UV-induced (25 J/m2) expression of the endogenous p21Cip1 gene in C33A cells treated with
control-siRNA, Miz-1-siRNA or transiently expressing HPV-16 E7, measured by quantitative RT-PCR. The values were normalized to β-actin. Values are the means±standard de-
viation of at least 3 independent measurements. (C) Effects of the siRNA-mediated knock down of Miz-1 and of transient expression of HPV-16 E7 on the p21Cip1 protein levels
in UV-irradiated (25 J/m2) C33A cells. The corresponding cell lysates were run onto a SDS-PAGE and the protein level of HPV-16 E7, p21Cip1, actin and Miz-1 are monitored by west-
ern blotting as indicated. The Miz-1 bands are indicated by arrows. (D) Detection of endogenous Miz-1 protein in different HPV-16 E7 expressing cells. Cell lysates were prepared
from NHEK, NHEK/HPV-16 E6 (Blasko et al., 2000), NHEK/HPV-16 E7 (Mannhardt et al., 2000) and CaSki cells (left panel) and from U-2OS and U-2OS cells transiently transfected
with pxHPV-16 E7 (right panel). Cell lysates were separated onto a SDS-PAGE and Miz-1 protein detected by western blotting using the anti-Miz-1 10E2 antibody. The expression of
the HPV-16 E7 protein was also corroborated. Actin served as input control. (E) HPV-16 E7 overrides Miz-1 induced G1-cell cycle arrest in UV-irradiated C33A cells. C33A cells were
transiently transfected with expression vectors for Miz-1, E7 or empty vector (mock) as indicated. Transfection efﬁciency of the C33A cells was over 90%. 24 h later the cells were
irradiated with 25 J/m2 UV and another 24 h later the cells were propidium-iodide stained and the cell cycle distribution was determined by ﬂow cytometry using a FACSCalibur.
The percentage number of cells in G1-phase is shown. Values are the means±standard deviation of three independent experiments.
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signiﬁcantly reduced (Fig. 6C). These results are consistent with the
reduced binding efﬁciency of the carboxyl-terminal E7 mutants to
Miz-1 (Fig. 1), reduced repression of Miz-1-dependent induction of
the endogenous p21Cip1 gene in C33A cells (Fig. 3) and the Miz-1-
dependent binding of E7 to the p21Cip1 core promoter in ChIP
(Fig. 5D). In contrast, E7C24G, which fails to bind and inactivate pRB
(Fiedler et al., 2004), was able to bind and repress Miz-1-induced
p21Cip1 gene expression with an efﬁciency similar to that of wild-
type E7. These data suggest that the ability of E7 to form a complex
with Miz-1 is consistent with the inhibition of Miz-1-driven transac-
tivation of p21Cip1 gene expression from the core promoter.
Discussion
The main ﬁnding of the present study is that HPV-16 E7 inhibits
UV-induced p21Cip1 gene expression in cervical cancer cells in a
Miz-1-dependent manner. The ability to inhibit p21Cip1 expression
depends on E7 binding and repressing the activity of the transcription
factor Miz-1 which is bound to the p21Cip1 core promoter and acti-
vates p21Cip1 gene expression. The ability of E7 to bind to Miz-1 and
to repress Miz-1-dependent p21Cip1 gene expression is signiﬁcantly
impaired by the C-terminal mutant E7Δ79LEDLL83 which exhibits re-
duced transforming activity (Massimi et al., 1997; Prathapam et al.,
2001), suggesting that the ability of E7 to abrogate the function of
Miz-1 contributes to its transforming capacity. This is underlined by
our ﬁnding that HPV-11 E7 cannot repress UV-irradiation induced ex-
pression of the p21Cip1 gene in C33A cells. Another E7 mutant, C24G,Fig. 4. HPV-16 E7 mediated repression of Miz-1-dependent p21Cip1gene expression after
(A) C33A cells were transiently transfected with either empty vector (mock) or expressio
were detected 24 h after transfection by western blotting. Pan-actin served as input contr
samples were extracted before and 6 h after UV irradiation and subjected to quantitativ
pan-actin. Values are the means±standard deviation of 3 independent measurements. (C)
HPV-11 E7 expression vector and with empty vector (mock). The expression of HPV-11 E7which is impaired in binding and inactivating the pRB family mem-
bers (Phelps et al., 1992), can bind to Miz-1 and inhibit Miz-1-
dependent p21Cip1 expression similar to wild-type E7. This suggests
that the interaction of E7 with pRB is not required for inactivation
of Miz-1 and strengthens the current model that several distinct reg-
ulatory pathways must be subverted by oncogenic E7 to transform
mammalian cells. This is in keeping with the results from numerous
genetic, cell biological and biochemical studies (reviewed in ref.
McLaughlin-Drubin and Munger, 2009; Pim and Banks, 2010; zur
Hausen, 2002).
HPV-16 E7 can abrogate DNA-damage induced inhibition of DNA
synthesis by various agents such as UV light, chemicals or ionizing ra-
diation (Demers et al., 1994; Jones et al., 1999; Seavey et al., 1999;
Slebos et al., 1994; Song et al., 1998). It is known that E7 can override
p53-mediated G1-cell cycle arrest in response to DNA damage
(Demers et al., 1994; Hickman et al., 1994); however, in cells expres-
sing wild-type p53, p53 protein levels after DNA damage are not de-
creased but increased by E7 (Eichten et al., 2002; Funk et al., 1997;
Jones et al., 1999; Seavey et al., 1999; Slebos et al., 1994; Song et al.,
1998), reviewed in ref. (McLaughlin-Drubin and Munger, 2009). In
fact, E7 has been shown to stabilize p53 (Seavey et al., 1999) but de-
spite the high levels of p53 in E7 expressing cells the transcription of
p53 target genes such as p21Cip1 is not activated (Jones et al., 1999),
and other studies showed that E7 represses transcriptional activation
of reporter genes by p53 (Eichten et al., 2002; Massimi and Banks,
1997), reviewed in Ref. McLaughlin-Drubin and Munger, 2009).
Thus the importance of the functional interaction between E7 and
p53 (both proteins does not physically interact) for E7-inducedUV irradiation is a function of the HPV-16 E7 carboxyl-terminal zinc-binding loop.
n vectors for HPV-16 E7 and HPV-16 E7 mutants, as indicated. The E7 protein levels
ol. (B) The transiently transfected C33A cells were irradiated with UV (25 J/m2); RNA
e PCR analysis to assess p21Cip1 mRNA expression. The values were normalized to
HPV-11 E7 expression in C33A cells. C33A cells were transiently transfected with an
was detected by q-RT-PCR. N=6.
Fig. 5. HPV-16 E7 binds to the p21Cip1core promoter. (A) Nucleotide sequence of the human p21Cip1 core promoter (−46/+156). TheMiz-1 binding sites are underlined. The primers for
the ampliﬁcation of the p21Cip1 promoter region are indicated by arrows. (B) Chromatin immunoprecipitation (ChIP) of human p21Cip1 core promoter (−46/+156) DNA. Chromatin
preparations from UV-treated and non-UV-treated CaSki cells were subjected to ChIP as indicated. The anti-HPV-16 E7 RabMab-42-3, anti-Miz-1 and anti-histone H3 antibodies co-
immunoprecipitated human p21Cip1 core promoter (−46/+156) DNA. Unrelated rabbit immune serum failed to immunoprecipitate this DNA sequence. The ampliﬁed DNA bands
were isolated from the agarose gel and the p21Cip1 core promoter (−46/+156) sequence veriﬁed by sequencing. The results are representative of three independent experiments. All
antibodies failed to immunoprecipitate an unresponsive control. (C) SiRNA mediated knock down of Miz-1 in CaSki cells. (left panel) SiRNA oligonucleotide mixes were used for both
Miz-1 and control siRNA (see ref. Herold et al., 2008). The efﬁciency of the siRNA-mediated Miz-1 knock down was analyzed by western blotting 72 h after transfection. Actin served
as input control. (Right panel) The Miz-1 and actin western blot bands were scanned from low exposures and densitometrically analyzed for quantiﬁcation (n=3). (D) ChIP of
human p21Cip1 core promoter (−46/+156) DNA in Miz-1-depleted CaSki cells. Chromatin preparations from control siRNA and Miz-1 siRNA CaSki cells were subjected to ChIP as
indicated. In control siRNA cells, the anti-HPV-16 E7 RabMab-42-3, anti-Miz-1 and anti-histone H3 antibodies co-immunoprecipitated human p21Cip1 core promoter (−46/+156)
DNA. Unrelated rabbit immuneserum failed to immunoprecipitate this DNA sequence. InMiz-1 siRNA cells, the anti-HPV-16 E7 RabMab-42-3, anti-Miz-1 antibodies and unrelated rabbit
immuneserum failed to co-immunoprecipitate human p21Cip1 core promoter (−46/+156) DNA. The ampliﬁed DNA bands were isolated from the agarose gel and the p21Cip1 core
promoter (−46/+156) sequence was veriﬁed by sequencing. The results are representative of three independent experiments.
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mains uncertain. In this study, we employed C33A cervical cancer
cells which express an inactive p53 protein mutated in the DNA bind-
ing domain (p53R273C) (Crook et al., 1991; Scheffner et al., 1991),
resulting in loss of DNA binding (Cho et al., 1994). This gave us the
opportunity to analyse p53-independent p21Cip1 gene expression.
We found that Miz-1 is necessary for UV-induced p21Cip1 expressionand subsequent cell cycle arrest in the C33A cells. Moreover, we could
show that E7 represses Miz-1-induced activation of p21Cip1 gene ex-
pression after UV irradiation in the C33A cells and this contributes
to the abrogation of Miz-1-induced G1-cell cycle arrest. C33A cells
responded with a moderate G1-cell cycle arrest to UV irradiation.
This might be due to the mutated p53 as well as pRB alleles in this
cell type (Crook et al., 1991; Scheffner et al., 1991; Zhu et al., 1993).
Fig. 6. HPV-16 E7 represses transactivation of the p21Cip1core promoter by Miz-1. (A) Schematic representation of the p21Cip1-core promoter (−93/+20)-luciferase reporter
construct. Miz-1 binds to the initiator element (Inr) indicated as gray box. (B) (Upper panel) HPV-16 E7-mediated repression of Miz-1-dependent transactivation of the reporter
pGL3-p21Cip1-core promoter (−93/+20)-luciferase in U-2OS cells. U-2OS cells were transiently transfected by Effectene with the pGL3-p21Cip1-core promoter (−93/+20)-
luciferase reporter gene construct in the presence or absence of Miz-1 and increasing amounts of HPV-16 E7, as indicated. A cytomegalovirus-driven β-galactosidase (β-Gal)
expression vector was co-transfected to control for transfection efﬁciency. The total amount of transfected DNA was always adjusted to 3 μg with empty vector pX. Luciferase
activity was normalized to β-Gal activity. The experiments were repeated in triplicate. The results are representative of three independent experiments. Shown are means±
standard deviations (SD). (Lower panel) Detection of the expressed effectors. U-2OS cells were transiently transfected with empty vector (mock), expression vectors for Miz-1
and HPV-16 E7, as indicated and the Miz-1 and E7 protein levels were detected 24 h after transfection by western blotting. M2-PK is shown as a loading control. (C) (Upper
panel) Repression of Miz-1-dependent transactivation of the reporter pGL3-p21Cip1-core promoter (−93/+20)-luciferase by HPV-16 E7 and HPV-16 E7 mutants in U-2OS cells.
U-2OS cells were transiently transfected by Effectene with the pGL3-p21Cip1-core promoter (−93/+20)-luciferase reporter gene construct in the presence or absence of Miz-1,
HPV-16 E7 and HPV-16 E7 mutants, as indicated. A cytomegalovirus-driven β-galactosidase (β-Gal) expression vector was co-transfected and luciferase activity was normalized
to β-Gal activity. The total amount of transfected DNA was always adjusted to 3 μg with empty vector pX. The experiments were repeated in triplicates. The results are represen-
tative of three independent experiments. The values shown are means±standard deviations (SD). (Lower panel) Detection of the transiently expressed, HPV-16 E7 and HPV-16 E7
mutants in U-2OS cells. The E7 protein levels were detected 24 h after transfection by western blotting. M2-PK is shown as a loading control.
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induced p21Cip1 gene expression contributes to G1/S cell cycle
progression.
Induced by UV irradiation Miz-1 binds to the p21Cip1 core promoter
and transactivates expression of the p21Cip1 gene (Herold et al., 2002;
Wu et al., 2003). Our results suggest a model in which E7 forms a com-
plexwithMiz-1 at the p21Cip1 core promoter in cervical cancer cells and
speciﬁcally inhibits transactivation byMiz-1whichwas activated byUV
irradiation. This results in the inhibition ofMiz-1-dependent expression
of the p21Cip1 gene. A similar mechanism was shown for c-Myc, which
can form a complex with Miz-1 at the core promoter of p21Cip1 and
thereby repress p21Cip1 gene expression in response to DNA damage
(Herold et al., 2002; Wu et al., 2003). In p53 wild-type cells thiscontributes to the inhibition of p21Cip1 induction by p53 from distal
p53 response elements after exposure to DNA damage and facilitates
p53-induced apoptosis by shifting the p53-response from anti-
proliferative to pro-apoptotic (Seoane et al., 2002). In analogy, our re-
sults raise the possibility that E7-mediated repression of Miz-1-
induced p21Cip1 gene expression could contribute to the inability of
p53 to induce p21Cip1 gene expression in p53 wild-type cells (Jones et
al., 1999). However, the role of E7 for p53-induced transactivation of
the p21Cip1 promoter warrants further study.
What could be the reason for HPV-16 to evolve a strategy to inacti-
vate the DNA-damage/Miz-1/p21Cip1 pathway by E7? Cells can respond
to DNA damage by undergoing cell cycle arrest (Garner and Raj, 2008).
In response to DNA damage signaling p53 is stabilized and induces the
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by p53 through its induction of p21Cip1. Like E7, E6, which induces pro-
teolysis of p53, also abrogates DNA-damage-induced cell cycle arrest
(Kessis et al., 1993). In fact, the p53 levels are quite low in HPV-
positive cervical cancer cells and in cells expressing HPV E6 or HPV
E6/E7 (reviewed in ref. McLaughlin-Drubin and Munger, 2009)). How-
ever, p21Cip1 can also be induced through p53-independent pathways
(Macleod et al., 1995). Thus, although p53-dependent antiproliferative
pathways are inactivated by E6, antiproliferative signals that cannot
be neutralized by E6 may affect the proliferation of HPV-16-infected
cells and thereby viral replication. In this scenario, E7-driven inactiva-
tion of Miz-1 may add to inhibition of p21Cip1 gene expression, and
hence downmodulation of the antiproliferative DNA-damage response
of the infected host cells. In fact it was shown that E7 can abrogate the
inhibition of DNA synthesis through both p53-dependent and p53-
independent pathways (Jones et al., 1999; Song et al., 1998).
Transition from G1 to S phase is regulated by G1/S CDKs that phos-
phorylate and thereby inactivate pRB (Garner and Raj, 2008). E7 dis-
rupts pRB/E2F complexes. This results in increased cyclin E and cyclin
A levels and contributes to the induction of DNA synthesis. Thus the
mechanisms by which E7 overrides DNA-damage induced inhibition
of DNA synthesis may include the inactivation of pRB and deregulated
expression of E2F transcriptional targets (Hickman et al., 1994). How-
ever, mutational analysis of E7 has shown that this activity is not sole-
ly responsible for cell transformation by E7 (reviewed in ref.
McLaughlin-Drubin and Munger, 2009). E7 stimulates proliferation
also independently of its ability to associate with pRB (Caldeira et
al., 2000) and inactivation of pRB by E7 is not sufﬁcient to overcome
cell cycle arrest in human keratinocytes (Helt and Galloway, 2001).
In keeping with these data, we showed in the present study that the
E7 cd2 mutant C24G, which is deﬁcient in binding to pRB, behaves
as wild-type E7 in the functional interaction between E7 and Miz-1.
Moreover, E7 contributes to abrogation of Miz-1-induced G1 cell
cycle arrest in the C33A cells which contain mutated pRB alleles.
This suggests that pRB-independent pathways contribute to HPV-16
E7-induced abrogation of DNA-damage induced G1/S cell cycle arrest
in C33A cells. Thus repression of the expression of the cdki p21Cip1 by
E7 could be a strategy to overcome cyclin-E-Cdk2 and cyclin-A-Cdk2
inhibition and hence activation of additional targets which are neces-
sary for cell cycle progression into S phase, such as the cyclin E-Cdk2
substrate NPAT (Zhao, 2004).
Several examples exist of tumor virus oncoproteins with diverse
and partially redundant functions (reviewed in ref. McLaughlin-
Drubin and Munger, 2008). The inactivation of the p21Cip1 protein
by physical interaction with E7 was previously shown as another
mechanism contributing to the ability of E7 to override pathways
inhibiting G1/S cell cycle transition after DNA damage (Funk et al.,
1997) and in differentiating keratinocytes (Jones et al., 1997). How-
ever, it was also shown that high-risk HPV E7 cannot override a cell
cycle arrest in HeLa cells induced by ectopic expression of p21Cip1
(Niculescu et al., 1998). Moreover, studies in differentiated keratino-
cytes in warty lesions and in raft cultures suggested that p21Cip1 is
only detectable in post-mitotic E7-expressing cells but not in E7-
expressing cells undergoing DNA synthesis (Banerjee et al., 2006;
Noya et al., 2001). These data suggest that E7 inactivates p21Cip1 by
more than one mechanism. The data reported here suggest a novel
mechanism contributing to E7-induced abrogation of DNA-damage
induced p21Cip1 expression by functional inactivation of Miz-1.Materials and methods
Yeast two-hybrid interaction analysis
The Y2-HS was performed essentially as described (Zwerschke et
al., 1999).Plasmid construction
pUHDMiz-1 (Herold et al., 2002), the HPV-16 E7 and HPV-11 E7 ex-
pression vectors (Mannhardt et al., 2000; Massimi et al., 1997;
Prathapam et al., 2001; Santer et al., 2007) are described. pGL3-p21Cip1-
promoter (−93/+20) containing the p21Cip1 core promoter from −93
to+20 (Wu et al., 2003) was generated by the insertion of the following
oligonucleotides into the Nhe/XhoI-site of pGL3 (Promega, Austria):
p21minpGL3 1 F: 5′-ctagcgagcgcgggtcccgcctccttgaggcgggcccgggcggggcg
gttgtatatca-3′; p21minpGL3 2 F: 5′-gggccgcgctgagctgcgccagctgaggtgtgag-
cagctgccgaagtcagttcgttgtg-3′; p21minpGL3 1R: 5′-cagcgcggccctgatata-
caaccgccccgcccgggcccgcctcaaggaggcgggacccgcgctcg-3′; p21minpGL3 2R:
5′-tcgagcacaaggaactgacttcggcagctgctcacacctcagctggcgcagct-3′
Cell culture and transfection
C33A cervical cancer cells and U-2OS osteosarcoma cells were cul-
tured in DMEM plus 10% FCS (Santer et al., 2007). Cells were tran-
siently transfected with 3 μg of various plasmids using
Lipofectamine 2000 (Invitrogen, California). Transfection efﬁciency
was controlled by co-transfecting pEGFP-C1 (Clontech, Germany) or
pBB14 expressing membrane-bound GFP (Brideau et al., 1998). The
transfection efﬁciency in both C33A and U-2OS cells was over 90%.
Transfection efﬁciency varied less than 10% between individual
experiments.
In vitro protein–protein interaction analysis
For GST pull-down assays, 10 ng/μl of GST and GST fusion proteins
containing various mutants of E7 (Santer et al., 2007) were loaded on
glutathione-Sepharose 4B beads. Total cell lysates from U-2OS cells
overexpressing Miz-1 were incubated with GST-E7 fusion proteins
and bound proteins were analyzed by western blotting using mono-
clonal anti-Miz-1 antibodies (Clone 10E2, ref. Herold et al., 2008).
Coimmunoprecipitation experiments
Co-IP in U-2OS cells: U-2OS cells cotransfectedwith pUHDMiz-1 and
pX-HPV-16 E7 were harvested in lysis buffer (50 mM HEPES pH7,
150 mM (HPV-16 E7 IP) or 300 mM (Miz-1 IP) NaCl, 0.1% NP-40,
10 mM ß-glycerophosphate, 100 μM Na3VO4, 0.2 mM PMSF, 1 mM
NaF, protease-inhibitor-mix no.1836170 (Roche, Germany). Total cell
lysates were subjected to immunoprecipitation either with afﬁnity-
puriﬁed goat anti-HPV-16 E7 antibodies (Fiedler et al., 2005), mouse
anti-Miz-1 antibodies (clone H-190, Santa Cruz), control mouse anti-
bodies, or goat pre-immune serum. Beads were washed three times in
lysis buffer and precipitated proteins were visualized by western blot-
ting using afﬁnity-puriﬁed polyclonal anti-HPV-16 E7 or mouse mono-
clonal anti–Miz-1 antibodies (clone 10E2;Wanzel et al., 2005;Herold et
al., 2008; Herkert et al., 2010), respectively, essentially as described
(Santer et al., 2007). Co-IP in CaSki cells: CaSki cells were harvested in
lysis buffer (50 mM HEPES pH7, 150 mM NaCl, 0.1% NP-40, 10 mM ß-
glycerophosphate, 100 μM Na3VO4, 0.2 mM PMSF, 1 mM NaF,
protease-inhibitor-mix no.1836170 (Roche, Germany). Total CaSki cell
lysates were subjected to immunoprecipitation either with the anti-
HPV-16 E7 RabMab42-3 (Dreier et al., 2011) or rabbit pre-immune
serum. Beads were washed three times in lysis buffer and precipitated
proteins were visualized by western blotting using afﬁnity-puriﬁed
polyclonal anti-HPV-16 E7 or mouse monoclonal anti-Miz-1 antibodies
(clone 10E2; Herkert et al., 2010; Herold et al., 2008; Wanzel et al.,
2005), respectively. Note that the mouse monoclonal anti-Miz-1 anti-
body (clone 10E2) recognizes more than one band of Miz-1 in western
blotting experiments (Herkert et al., 2010; Herold et al., 2008; Wanzel
et al., 2005). These bands represent most likely post-translational mod-
iﬁcations of Miz-1 (Herkert et al., 2010; Wanzel et al., 2005).
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C33A cells transiently transfected (transfection efﬁciency >90 %)
with pX, pX-HPV-16 E7 and/or pUHDMiz-1 were cultured in DMEM
plus 10% FCS and 24 h later UV irradiated with 25 J/m2. 24 h later
these cells were resuspended in Nicoletti buffer and the cell cycle pro-
ﬁles of PI-stained nuclei were measured by FACS analysis (FACSCali-
bur, Becton Dickenson, Austria). Cell cycle distribution was analyzed
using ModFit software (Becton Dickenson, Austria).
SiRNA experiments
C33A cells were seeded in 6-well plates, maintained until 70% con-
ﬂuency and were then transfected with 100 nM siRNA oligonucleo-
tide mixes for Miz-1 and control siRNA (Herold et al., 2008) using
Lipofectamine 2000 (Invitrogen, UK). 70 h after transfection cells
were subjected to UV irradiation (25 J/m2) with subsequent Quanti-
tative RT-PCR (6–8 h after UV irradiation) or western blotting.
Luciferase reporter gene assays
U-2OS cells were seeded in 6-well plates and transiently trans-
fected using the Lipofectamine 2000 (Invitrogen, California) with
pGL3, pGL3-p21Cip1-promoter (−93/+20) and expression vectors
for Miz-1, HPV-16 E7 and mutants thereof. 24 h after transfection lu-
ciferase activity from at least 3 independent transfections was mea-
sured in an Anthos Lucy 1 photoluminometer (Anthos Labtec
Instruments, Austria).
Quantitative RT-PCR experiments
RNA was puriﬁed using the RNeasy Kit (Quiagen, Germany). RNA
was transcribed to cDNA using the First Strand cDNA Synthesis Kit
(Fermentas, Ontario). Real-Time PCR was performed with iQ Sybr
Green Supermix (Biorad, California) using a iCycler (Biorad, Califor-
nia). The ﬁnal concentration of primers was 500 nM. Primer: β-actin
forward LC 5′-GACGACATGGAGAAAATCTG-3′; β-actin reverse LC 5′-
ACATGATCTGGGTCATCTTCT-3′; p21-LC1 5′-GGCGGCAGACCAGCAT-
GACAGATT-3′; p21-LC2: 5′-GCAGGGGGCGGCCAGGGTAT-3′. HPV-11
E7 forward 5′-TGGACAAGGTGGACAAACAA-3′; HPV-11 E7 reverse
5′-TAGTGTGCCCAGCAAAAGCT-3′.
Western blot analysis
Western blot analysis was performed as described (Mück et al.,
2010). Antibodies against Miz-1: IPs: clone H-190, Santa Cruz Bio-
technology; Western blot: Miz-1 clone 10E2 (Herold et al., 2008),
p21Cip1 (clone N20, Santa Cruz Biotechnology), Pan-actin (clone
ACTN05 Labvision, California), p300 (BD Pharmingen), Myc (9E10,
Santa Cruz Biotechnology). Anit-HPV-16 E7 antibodies: afﬁnity-
puriﬁed rabbit and goat anti-HPV-16 E7 antibodies (Fiedler et al.,
2004, 2005), RabMab42-3 (Dreier et al., 2011).
UV-irradiation experiments
Cells were seeded in 6-well plates and transiently transfected with
the corresponding expression vectors. 24 h later, cells were washed
with PBS, covered with 25 μl/cm2 PBS and irradiated with 25 J/m²
UV in CL 1000 Cross linker from UVP, Inc (Upland, California). Cells
were further processed 6–8 h after irradiation.
Chromatin immunoprecipitation (ChIP) assay
ChIP was conducted according to the SimpleChIP™ Enzymatic
Chromatin IP Kit (Cell Signaling Technology, Inc, Danvers, MA,
USA). For the immune-precipitation of chromatin complexes 18 μgprecleared chromatin was incubated with sepharose beads and
5 μg of monoclonal rabbit anti-HPV-16 E7 antibodies (RabMab42-
3) (Dreier et al., 2011), anti Miz-1 antibody (Clone C-19, Santa
Cruz Biotechnology, Inc. Heidelberg, Germany), anti-Histone H3
RabMab (Clone D2B12, Cell Signaling Technology, Inc, Danvers,
MA, USA) and unrelated rabbit immune-serum (Cell Signaling Tech-
nology, Inc, Danvers, MA, USA), respectively. To detect the sequence
of the human p21Cip1-core promoter (−46/+156) the samples
were analyzed by RT-PCR using the forward primer 5′-AGC GCG
GGT CCC GCC TCC TTG AG-3′and the reverse primer 5′-CGG CCC
GGG GTC CCC TGT TGT CT-3′, essentially as described (Ceballos et
al., 2005).
Statistical analysis
Statistical signiﬁcances were calculated using the unpaired t-test
(GraphPad PRISM version 3.03).
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